Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
EyePoint Pharmaceuticals to Cut 53% of Workforce After Eye Disease Drug Trial Setback

EyePoint Pharmaceuticals to Cut 53% of Workforce After Eye Disease Drug Trial Setback

MT newswireMT newswire2026/10/19 12:08
08:08 AM EDT, 10/19/2026 (MT Newswires) -- EyePoint Pharmaceuticals (EYPT) said Monday that it plans to cut 53% of its workforce and end its late-stage trials of Duravyu for wet age-related macular degeneration early after the drug failed to meet the primary endpoint. The company said Duravyu improved vision and met key secondary endpoints related to treatment burden, supplement-free rates, disease control and safety with redosing, but failed to demonstrate non-inferiority on the primary endpoint. EyePoint said it will focus its resources on developing Duravyu for diabetic macular edema, with results from two pivotal late-stage trials expected in Q4 of next year. The restructuring is expected to generate $30 million in annualized savings, with one-time employee separation costs of $9 million, the company said. EyePoint had $118 million in cash, cash equivalents and short-term investments as of Sept. 30, 2026. Most workforce reductions are expected in Q4, with the process scheduled to conclude in H1 of next year, it added. Shares of the company were down more than 80% in recent Monday premarket activity.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The Bank of Japan’s most hawkish board member says rate hikes do not need to follow a fixed schedule, while markets see an 85% probability of action in December.

Bank of Japan board member Hajime Takata stated that interest rate hikes should be adjusted flexibly in terms of scale and pace, and that interest rates have only just approached the neutral range. OIS shows an approximately 85% probability of a rate hike on December 18, with the yen hovering around 159.57.

智通财经•2026/11/16 07:48

AI concept blank check company Compute AI (AICPU.US) files for IPO: plans to raise $75 million and list on Nasdaq

Compute AI Acquisition, a blank-check company in the AI sector, has applied for an IPO on Nasdaq, planning to issue 7.5 million units at $10 per unit, aiming to raise up to $75 million.

智通财经•2026/11/16 07:26
AI concept blank check company Compute AI (AICPU.US) files for IPO: plans to raise $75 million and list on Nasdaq